[HTML][HTML] The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020)

M Egi, H Ogura, T Yatabe, K Atagi, S Inoue, T Iba… - Journal of intensive …, 2021 - Springer
Abstract The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic
Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis …

Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials

KZ Vardakas, GL Voulgaris, A Maliaros… - The Lancet infectious …, 2018 - thelancet.com
Background The findings of randomised controlled trials (RCT), observational studies, and
meta-analyses vary regarding the effectiveness of prolonged β-lactam infusion. We aimed to …

Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials

JA Roberts, MH Abdul-Aziz, JS Davis… - American journal of …, 2016 - atsjournals.org
Rationale: Optimization of β-lactam antibiotic dosing for critically ill patients is an intervention
that may improve outcomes in severe sepsis. Objectives: In this individual patient data meta …

[HTML][HTML] Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta …

MH Abdul-Aziz, H Sulaiman, MB Mat-Nor, V Rai… - Intensive care …, 2016 - Springer
Purpose This study aims to determine if continuous infusion (CI) is associated with better
clinical and pharmacokinetic/pharmacodynamic (PK/PD) outcomes compared to intermittent …

[HTML][HTML] Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients

RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …

[HTML][HTML] Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

J Gonçalves-Pereira, P Póvoa - Critical Care, 2011 - Springer
Introduction Several reports have shown marked heterogeneity of antibiotic
pharmacokinetics (PK) in patients admitted to ICUs, which might potentially affect outcomes …

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial

JM Dulhunty, JA Roberts, JS Davis… - Clinical infectious …, 2013 - academic.oup.com
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta …

ME Falagas, GS Tansarli, K Ikawa… - Clinical infectious …, 2013 - academic.oup.com
We sought to study whether the better pharmacokinetic and pharmacodynamic (PK/PD)
properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is …

Pseudomonas aeruginosa ventilator-associated pneumonia management

S Ramírez-Estrada, B Borgatta… - Infection and drug …, 2016 - Taylor & Francis
Ventilator-associated pneumonia is the most common infection in intensive care unit
patients associated with high morbidity rates and elevated economic costs; Pseudomonas …

[HTML][HTML] Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy

J Mensa, J Barberán, A Soriano, P Llinares… - Revista Española de …, 2018 - ncbi.nlm.nih.gov
Pseudomonas aeruginosa is characterized by a notable intrinsic resistance to antibiotics,
mainly mediated by the expression of inducible chromosomic β-lactamases and the …